MIRHIQL Resource Center for Improving Quality of Life with Chronic Pain (MRC)
MIRHIQL 改善慢性疼痛生活质量资源中心 (MRC)
基本信息
- 批准号:10705887
- 负责人:
- 金额:$ 597.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-15 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary
Despite acknowledging the challenges of long-term opioid use (LTOT) in clinical and research studies, there is
no consensus on clinically defining opioid misuse. In clinical practice, screening and risk/benefit calculations
remain difficult because while opioid use can be problematic, it may be beneficial in certain subpopulations.
The combination of variables that could be used clinically to assess the risk of harms versus quality of life for
people on LTOT has not been established. It may be possible to decrease some of the tension between
prescribers and patients if clinical providers have a working clinical definition and improved ways of assessing
whether a patient is a candidate for LTOT. The MIRHIQL Resource Center's (MRC) long-term goal is to
understand how chronic pain (CP) and related factors influence the progression of LTOT behaviors. The
objective of MRC center is to create a research community that connects the MIRHIQL network to IMPOWR
research centers and larger HEAL network to translate findings while developing a key opioid misuse and
LTOT infrastructure. We hypothesize that defining opioid misuse and the LTOT benefit/risk framework will
require integrated patient-centered clinical approaches that address the systemic issues affecting healthcare
delivery and the patient-provider interaction, leading to a fundamental shift in how healthcare providers and the
public are educated. These goals will be achieved through the following specific aims: (1) the MRC will
harmonize data collection and common data elements for the MIRHIQL network, providing coordinated support
for network activities while connecting to the IMPOWR Network and larger HEAL Ecosystem via our IMPOWR
CC, (2) The MRC will clinically define opioid misuse with associated risks/benefits using an interconnected
strategy including multi-society expert Delphi, qualitative interviewing of prescribers and people with lived pain
experience, and phenotyping and validating cohort definitions in electronic health and administrative claims
data, and (3) The MRC will perform analytical and clinical validation of screening and benefit/risk tools for
LTOT and definition of opioid misuse in a cohort trial comparing different combinations of relevant OM
variables. Usability (system/provider input) and user experience (provider/patient input) will evaluated for
clinical utility in real-world clinical settings. These aims will provide a coordinated integration of systematic
review, qualitative interviewing, EHR and claims data, and expert Delphi Taskforce to identify and test
candidate variables for a clinical definition of opioid misuse and develop screening and risk/benefit tools for
clinical care. The proposed research is innovative because we will be able to leverage the large-scale claims
(CMS and private payer) and EHR data to build a framework for LTOT care on a rapid timeline. These results
will support future research but will also have direct clinical impact, aligning with NIH HEAL's mission.
项目摘要
尽管承认临床和研究中长期使用阿片类药物(LTOT)的挑战,但仍有
对临床定义阿片类药物滥用没有共识。在临床实践中,筛查和风险/福利计算
保持困难,因为尽管使用阿片类药物可能会出现问题,但它可能对某些亚群有益。
可以在临床上使用变量的组合来评估危害风险与生活质量的风险
LTOT上的人尚未建立。可能会减少之间的某些张力
处方者和患者如果临床提供者具有工作的临床定义,并改进了评估方法
患者是否是LTOT的候选人。 Mirhiql资源中心(MRC)的长期目标是
了解慢性疼痛(CP)和相关因素如何影响LTOT行为的发展。这
MRC中心的目的是建立一个将MirhiQl网络连接到Impowr的研究社区
研究中心和更大的治疗网络,以在开发关键阿片类药物滥用和
LTOT基础架构。我们假设定义阿片类药物滥用和LTOT福利/风险框架将
需要以患者为中心的综合临床方法来解决影响医疗保健的系统问题
交付和患者提供者的互动,导致医疗保健提供者和
公众受过教育。这些目标将通过以下特定目的实现:(1)MRC将
协调MirhiQL网络的数据收集和共同数据元素,提供协调支持
通过我们的Impowr连接到Impowr网络和更大的治疗生态系统的网络活动
CC,(2)MRC将使用互连
包括多社会专家Delphi在内的策略,处方者的定性访谈和生命痛苦的人
经验,表型和验证电子健康和行政主张中的队列定义
数据,(3)MRC将对筛查的分析和临床验证以及利益/风险工具
在比较相关OM的不同组合的队列试验中,LTOT和阿片类药物滥用的定义
变量。将评估可用性(系统/提供商输入)和用户体验(提供者/患者输入)
现实世界中临床环境中的临床实用性。这些目标将提供系统的协调整合
审查,定性访谈,EHR和索赔数据以及专家Delphi工作组以识别和测试
候选变量,用于滥用阿片类药物的临床定义,并开发筛查和风险/利益工具
临床护理。拟议的研究具有创新性,因为我们将能够利用大规模主张
(CMS和私人付款人)和EHR数据,以在快速时间表上建立LTOT护理框架。这些结果
将支持未来的研究,但也将产生直接的临床影响,与NIH Heal的使命保持一致。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
MEREDITH C. B. ADA...的其他基金
COVID-19 Pandemic Mitigation, Community Economic and Social Vulnerability, and Opioid Use Disorder
COVID-19 流行病缓解、社区经济和社会脆弱性以及阿片类药物使用障碍
- 批准号:1065323810653238
- 财政年份:2022
- 资助金额:$ 597.81万$ 597.81万
- 项目类别:
WF DISC: Navigating Data Solutions for Chronic Pain and Opioid Use Disorder
WF DISC:探索慢性疼痛和阿片类药物使用障碍的数据解决方案
- 批准号:1058759410587594
- 财政年份:2022
- 资助金额:$ 597.81万$ 597.81万
- 项目类别:
WF DISC: Navigating Data Solutions for Chronic Pain and Opioid Use Disorder
WF DISC:慢性疼痛和阿片类药物使用障碍的数据解决方案导航
- 批准号:1070894510708945
- 财政年份:2022
- 资助金额:$ 597.81万$ 597.81万
- 项目类别:
Wake Forest IMPOWR Dissemination Education and Coordination Center (IDEA-CC)
维克森林 IMPOWR 传播教育和协调中心 (IDEA-CC)
- 批准号:1060117210601172
- 财政年份:2022
- 资助金额:$ 597.81万$ 597.81万
- 项目类别:
Wake Forest IMPOWR Dissemination Education and Coordination Center (IDEA-CC)
维克森林 IMPOWR 传播教育和协调中心 (IDEA-CC)
- 批准号:1066574610665746
- 财政年份:2021
- 资助金额:$ 597.81万$ 597.81万
- 项目类别:
Wake Forest IMPOWR Dissemination Education and Coordination Center (IDEA-CC)
维克森林 IMPOWR 传播教育和协调中心 (IDEA-CC)
- 批准号:1037878610378786
- 财政年份:2021
- 资助金额:$ 597.81万$ 597.81万
- 项目类别:
Wake Forest IMPOWR Dissemination Education and Coordination Center (IDEA-CC)
维克森林 IMPOWR 传播教育和协调中心 (IDEA-CC)
- 批准号:1086683610866836
- 财政年份:2021
- 资助金额:$ 597.81万$ 597.81万
- 项目类别:
Wake Forest IMPOWR Dissemination Education and Coordination Center (IDEA-CC)
维克森林 IMPOWR 传播教育和协调中心 (IDEA-CC)
- 批准号:1059331210593312
- 财政年份:2021
- 资助金额:$ 597.81万$ 597.81万
- 项目类别:
Identifying opioid response phenotypes in low back pain electronic health data
识别腰痛电子健康数据中的阿片类药物反应表型
- 批准号:93135449313544
- 财政年份:2017
- 资助金额:$ 597.81万$ 597.81万
- 项目类别:
Identifying opioid response phenotypes in low back pain electronic health data
识别腰痛电子健康数据中的阿片类药物反应表型
- 批准号:98976329897632
- 财政年份:2017
- 资助金额:$ 597.81万$ 597.81万
- 项目类别:
相似海外基金
Testing Approaches to Promote Breast Cancer Screening in Rural Ghana
促进加纳农村地区乳腺癌筛查的测试方法
- 批准号:1064544610645446
- 财政年份:2023
- 资助金额:$ 597.81万$ 597.81万
- 项目类别:
Unraveling how Lipophilic Modulators Alter pLGIC Function via Interactions with the M4 Transmembrane Helix
揭示亲脂性调节剂如何通过与 M4 跨膜螺旋相互作用改变 pLGIC 功能
- 批准号:1078575510785755
- 财政年份:2023
- 资助金额:$ 597.81万$ 597.81万
- 项目类别:
Characterizing the genetic etiology of delayed puberty with integrative genomic techniques
利用综合基因组技术表征青春期延迟的遗传病因
- 批准号:1066360510663605
- 财政年份:2023
- 资助金额:$ 597.81万$ 597.81万
- 项目类别:
Social Vulnerability, Sleep, and Early Hypertension Risk in Younger Adults
年轻人的社会脆弱性、睡眠和早期高血压风险
- 批准号:1064314510643145
- 财政年份:2023
- 资助金额:$ 597.81万$ 597.81万
- 项目类别:
ACTS (AD Clinical Trial Simulation): Developing Advanced Informatics Approaches for an Alzheimer's Disease Clinical Trial Simulation System
ACTS(AD 临床试验模拟):为阿尔茨海默病临床试验模拟系统开发先进的信息学方法
- 批准号:1075367510753675
- 财政年份:2023
- 资助金额:$ 597.81万$ 597.81万
- 项目类别: